<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="id">1353</item><item key="factors"><item><item key="GSM545849"><item key="TRANSFECTION">Myb siRNA</item></item></item><item><item key="GSM545848"><item key="TRANSFECTION">non-targeting siRNA</item></item></item><item><item key="GSM545847"><item key="TRANSFECTION">mock</item></item></item></item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">3</item><item key="summary_wrapped">The c-Myb transcription factor is highly expressed in immature hematopoietic cells and down-regulated during differentiation. To define...</item><item key="pubmed_id">20686118</item><item key="geo_gse_id">E-GEOD-21943</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">3</item><item key="tags"><item>cell</item><item>macrophage</item><item>monocyte</item><item>protein</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">myb-silencing-in-cd14-myeloblasts</item><item key="geo_id_plat">E-GEOD-21943_A-AFFY-33</item><item key="name">MYB silencing in CD14-myeloblasts</item><item key="created">Jun.19, 2014</item><item key="summary">The c-Myb transcription factor is highly expressed in immature hematopoietic cells and down-regulated during differentiation. To define the role of c-Myb during the terminal differentiation of hematopoietic precursors, we studied the effects of its silencing in human primary CD14-myeloblasts, which maintain a granulo-monocyte differentiation bipotentiality. c-Myb-silenced myeloblasts were blocked in the G1 phase of the cell cycle at 24 hours post-nucleofection and subsequently were forced towards macrophage differentiation, as demonstrated by immunophenotypic and morphological analysis. Indeed, c-Myb-silenced CD14- cells differentiate to macrophage even after the treatment with ATRA 10-6 M,  demonstrating that the c-Myb knockdown strongly impairs the ability of myeloblasts to differentiate to granulocytes. Gene expression profiling of c-Myb-silenced CD14- cells identified some potential c-Myb targets that can account for these effects. To maximize siRNA transfection efficiency, we utilized the NucleofectorTM technology (Amaxa). CD14- cells were transfected with a mixture of 3 siRNAs targeting c-Myb mRNA, with a non-targeting siRNA as a negative control (NegCTR) and without siRNA (MOCK). c-Myb siRNAs were transfected at days 1 to 3 after the CD14- myeloblasts purification based on the observation that this timing represented a phase of phisiological increase in c-Myb expression in myeloblasts. Western Blot analysis at 24 hours post-nucleofection demonstrated the c-Myb protein knockdown in MYBsiRNA CD14- cells as compared with control samples (MOCK, NegCTR).</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-21943</item><item key="species">human</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-21943/samples/</item></data></biogps>
